Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Jansson L, Fischer G.

J Matern Fetal Neonatal Med. 2012 Jul;25(7):1197-201. doi: 10.3109/14767058.2011.653423. Epub 2012 Feb 17. No abstract available.

PMID:
22292518
2.

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

McCarthy JJ.

J Matern Fetal Neonatal Med. 2012 Feb;25(2):109-12. doi: 10.3109/14767058.2011.600371. Epub 2011 Aug 25. Review.

PMID:
21867403
3.

Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.

Jones HE, Johnson RE, Jasinski DR, Milio L.

Drug Alcohol Depend. 2005 Apr 4;78(1):33-8.

PMID:
15769555
4.

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Kakko J, Heilig M, Sarman I.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.

PMID:
18355989
6.

Fetal addiction to methadone: postnatal abstinence syndrome and development of visual evoked potentials.

Pinto F, Onofrj M, Pola P, Tempesta E, Torrioli MG.

Drug Alcohol Depend. 1986 Sep;18(1):1-10.

PMID:
3780406
7.

Fetal stress from methadone withdrawal.

Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R.

Am J Obstet Gynecol. 1975 May 1;122(1):43-6.

PMID:
1130446
8.

Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome.

Harper RG, Solish G, Feingold E, Gersten-Woolf NB, Sokal MM.

Am J Obstet Gynecol. 1977 Oct 15;129(4):417-24.

PMID:
910821
9.

The narcotic-dependent mother: fetal and neonatal consequences.

Kandall SR, Albin S, Gartner LM, Lee KS, Eidelman A, Lowinson J.

Early Hum Dev. 1977 Oct;1(2):159-69.

PMID:
617308
10.

[Pregnancy and drug dependence].

Clementi F, Grassi G.

Minerva Med. 1985 Mar 24;76(12):563-6. Italian.

PMID:
3991028
11.

Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.

San L, Camí J, Fernández T, Ollé JM, Peri JM, Torrens M.

Br J Addict. 1992 Jan;87(1):55-62.

PMID:
1311974
12.

[Infants of drug-addicted mothers: pitfalls of replacement therapy].

Vert P, Hamon I, Hubert C, Legagneur M, Hascoet JM.

Bull Acad Natl Med. 2008 May;192(5):961-9; discussion 969. French.

PMID:
19238786
13.

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L.

Drug Alcohol Depend. 2005 Jul;79(1):1-10.

PMID:
15943939
14.

Fetal abstinence: differing viewpoints?

Newman RG, Gevertz SG.

J Matern Fetal Neonatal Med. 2013 Jan;26(1):109. doi: 10.3109/14767058.2012.724485. Epub 2012 Sep 24. No abstract available.

PMID:
22928542
15.
16.
17.

Management of chemical dependence in pregnancy.

Christensen C.

Clin Obstet Gynecol. 2008 Jun;51(2):445-55. doi: 10.1097/GRF.0b013e31816fea77. Review.

PMID:
18463473
18.

[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].

Loustauneau A, Auriacombe M, Daulouede JP, Tignol J.

Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Review. French.

PMID:
12518080
19.
20.

Methadone assays in pregnant women and progeny.

Blinick G, Inturrisi CE, Jerez E, Wallach RC.

Am J Obstet Gynecol. 1975 Mar 1;121(5):617-21.

PMID:
1115163

Supplemental Content

Support Center